End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported

Eric French, Jeremy McCauley, Maria Aragon, Pieter Bakx, Martin Chalkley, Stacey H. Chen, Bent Jesper Christensen, Hongwei Chuang, Aurelie Côté-Sergent, Mariacristina De Nardi, Elliott Fan (), Damien Échevin, Pierre Geoffard, Christelle Gastaldi-Ménager, Mette Gørtz, Yoko Ibuka, John Jones, Malene Kallestrup-Lamb, Martin Karlsson, Tobias Klein, Grégoire de Lagasnerie (), Pierre-Carl Michaud, Owen O’donnell, Nigel Rice, Jonathan Skinner, Eddy Van Doorslaer, Nicolas Ziebarth () and Elaine Kelly
Authors registered in the RePEc Author Service: Owen O'Donnell

PSE-Ecole d'économie de Paris (Postprint) from HAL

Abstract: Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009–11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.

Date: 2017-07
References: Add references at CitEc
Citations: View citations in EconPapers (12)

Published in Health Affairs, 2017, 36 (7), pp.1211-1217. ⟨10.1377/hlthaff.2017.0174⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Working Paper: End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported (2017)
Working Paper: End-of-life medical spending in last twelve months of life is lower than previously reported (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:pseptp:halshs-01631529

DOI: 10.1377/hlthaff.2017.0174

Access Statistics for this paper

More papers in PSE-Ecole d'économie de Paris (Postprint) from HAL
Bibliographic data for series maintained by Caroline Bauer ().